Invivyd (IVVD) EPS (Basic) (2021 - 2026)
Invivyd's (IVVD) quarterly EPS (Basic) came in at -$0.14 in Q2 2026, down 13.95% on a YoY basis from -$0.17 in Q2 2025, and down 96.14% quarter-over-quarter from -$0.07 in Q4 2025.
Powered by 
Analysis
Invivyd (IVVD) EPS (Basic) (2021 - 2026) Analysis & Trends
Invivyd (IVVD) has reported EPS (Basic) for 6 consecutive years, with -$0.14 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) fell 13.95% year-over-year to -$0.14; the trailing twelve-month figure through Jun 2026 stood at -$0.26 (up 72.13% YoY), and the FY2025 full-year result was -$0.32, up 78.38% from the prior year.
- EPS (Basic) retreated to -$0.14 in Q2 2026 per IVVD's latest filing, from -$0.07 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.06 in Q3 2025 and bottomed at -$0.93 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.37 across 5 years, with a median of -$0.4 in 2024.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) surged 99.73% in 2022, then plunged 57.37% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.45 in 2022, then plunged by 57.37% to -$0.7 in 2023, then soared by 76.85% to -$0.16 in 2024, then jumped by 55.05% to -$0.07 in 2025, then plunged by 96.14% to -$0.14 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.14, -$0.07, and -$0.06 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.66 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.06 |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | -0.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.06 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -0.52 |
| Jun 30, 2024 | -0.41 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | -0.39 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -0.45 |
| Sep 30, 2022 | -0.44 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -1.95 |
| Sep 30, 2021 | -0.98 |
| Jun 30, 2021 | -178.86 |